請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21681
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 鍾國彪(Kuo-Piao Chung) | |
dc.contributor.author | Han-Ting Wei | en |
dc.contributor.author | 衛漢庭 | zh_TW |
dc.date.accessioned | 2021-06-08T03:42:22Z | - |
dc.date.copyright | 2019-08-26 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-06-19 | |
dc.identifier.citation | 1. Friedman RC, Downey JI. Internalized homophobia and gender-valued self-esteem in the psychoanalysis of gay patients. Psychoanal Rev. Jun 1999;86(3):325-347.
2. Waldner LK, Sikka A, Baig S. Ethnicity and sex differences in university students' knowledge of AIDS, fear of AIDS, and homophobia. J Homosex. 1999;37(3):117-133. 3. Klamen DL, Grossman LS, Kopacz DR. Medical student homophobia. J Homosex. 1999;37(1):53-63. 4. Christensen M. Homophobia in nursing: a concept analysis. Nurs Forum. Apr-Jun 2005;40(2):60-71. 5. Preskorn SH. Ketamine: the hopes and the hurdles. Biol Psychiatry. Oct 1 2012;72(7):522-523. 6. Morgan CJ, Curran HV. Ketamine use: a review. Addiction. Jan 2012;107(1):27-38. 7. Wakabi W. 'Homophobia is fuelling the AIDS epidemic in Africa'. CMAJ. Oct 23 2007;177(9):1017. 8. Dinkel S, Patzel B, McGuire MJ, Rolfs E, Purcell K. Measures of homophobia among nursing students and faculty: a Midwestern perspective. Int J Nurs Educ Scholarsh. 2007;4:Article24. 9. Ward EG. Homophobia, hypermasculinity and the US black church. Cult Health Sex. Sep-Oct 2005;7(5):493-504. 10. Igartua KJ, Gill K, Montoro R. Internalized homophobia: a factor in depression, anxiety, and suicide in the gay and lesbian population. Can J Commun Ment Health. Fall 2003;22(2):15-30. 11. Middela S, Pearce I. Ketamine-induced vesicopathy: a literature review. Int J Clin Pract. Jan 2011;65(1):27-30. 12. Guindon MH, Green AG, Hanna FJ. Intolerance and psychopathology: toward a general diagnosis for racism, sexism, and homophobia. Am J Orthopsychiatry. Apr 2003;73(2):167-176. 13. Huebner DM, Davis MC, Nemeroff CJ, Aiken LS. The impact of internalized homophobia on HIV preventive interventions. Am J Community Psychol. Jun 2002;30(3):327-348. 14. Curran HV, Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction. Apr 2000;95(4):575-590. 15. Swan GE, Carmelli D, LaRue A. Performance on the digit symbol substitution test and 5-year mortality in the Western Collaborative Group Study. Am J Epidemiol. Jan 1 1995;141(1):32-40. 16. Butler B. Death qualification and prejudice: the effect of implicit racism, sexism, and homophobia on capital defendants' right to due process. Behav Sci Law. 2007;25(6):857-867. 17. Kole SK. Globalizing queer? AIDS, homophobia and the politICSI of sexual identity in India. Global Health. Jul 11 2007;3:8. 18. Ding Y, He N, Zhu W, Detels R. Sexual Risk Behaviors among Club Drug Users in Shanghai, China: Prevalence and Correlates. AIDS Behav. Dec 18 2012. 19. Sih K, Campbell SG, Tallon JM, Magee K, Zed PJ. Ketamine in adult emergency medicine: controversies and recent advances. Ann Pharmacother. Dec 2011;45(12):1525-1534. 20. Smith HS. Ketamine-induced urologic insult (KIUI). Pain Physician. Nov-Dec 2010;13(6):E343-346. 21. Parsons JT, Grov C, Kelly BC. Club drug use and dependence among young adults recruited through time-space sampling. Public Health Rep. Mar-Apr 2009;124(2):246-254. 22. Jerome RC, Halkitis PN, Siconolfi DE. Club drug use, sexual behavior, and HIV seroconversion: a qualitative study of motivations. Subst Use Misuse. 2009;44(3):431-447. 23. Rasmussen SJ. Boundaries, exclusion, and oppression in 'the psychological basis of homophobia: cultural construction of a barrier'. Integr Psychol Behav Sci. Dec 2007;41(3-4):308-318; discussion 326-334. 24. Rosik CH, Griffith LK, Cruz Z. Homophobia and conservative religion: toward a more nuanced understanding. Am J Orthopsychiatry. Jan 2007;77(1):10-19. 25. Sandfort TG, Melendez RM, Diaz RM. Gender nonconformity, homophobia, and mental distress in latino gay and bisexual men. J Sex Res. May 2007;44(2):181-189. 26. Lieberman JS. Psychoanalytic reflections on the body in racism, homophobia and misogyny. Int J Psychoanal. Dec 2007;88(Pt 6):1543-1549. 27. Epprecht M. Black skin, 'cowboy' masculinity: a genealogy of homophobia in the African nationalist movement in Zimbabwe to 1983. Cult Health Sex. May 2005;7(3):253-266. 28. Ross MW, Kajubi P, Mandel JS, McFarland W, Raymond HF. Internalized homonegativity/homophobia is associated with HIV-risk behaviours among Ugandan gay and bisexual men. Int J STD AIDS. May 2013;24(5):409-413. 29. Kubicek K, McDavitt B, Carpineto J, Weiss G, Iverson E, Kipke MD. 'God Made me Gay for a Reason': Young Men who have Sex with Men's Resiliency in Resolving Internalized Homophobia from Religious Sources. J Adolesc Res. Sep 01 2009;24(5):601-633. 30. Davies M, Gilston J, Rogers P. Examining the relationship between male rape myth acceptance, female rape myth acceptance, victim blame, homophobia, gender roles, and ambivalent sexism. J Interpers Violence. Sep 2012;27(14):2807-2823. 31. Brown J, Trevethan R. Shame, internalized homophobia, identity formation, attachment style, and the connection to relationship status in gay men. Am J Mens Health. Sep 2010;4(3):267-276. 32. Kingston RE, Marel C, Mills KL. A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia. Drug Alcohol Rev. Oct 27 2016. 33. Steer RA, Cavalieri TA, Leonard DM, Beck AT. Use of the Beck Depression Inventory for Primary Care to screen for major depression disorders. Gen Hosp Psychiatry. Mar-Apr 1999;21(2):106-111. 34. Berrigan LI, Fisk JD, Walker LA, et al. Reliability of regression-based normative data for the oral symbol digit modalities test: an evaluation of demographic influences, construct validity, and impairment classification rates in multiple sclerosis samples. Clin Neuropsychol. 2014;28(2):281-299. 35. Novy DM, Nelson DV, Berry LA, Averill PM. What does the Beck Depression Inventory measure in chronic pain?: a reappraisal. Pain. May 1995;61(2):261-270. 36. Leentjens AF, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. Feb 15 2011;26(3):407-415. 37. Charvet LE, Beekman R, Amadiume N, Belman AL, Krupp LB. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS). J Neurol Sci. Jun 15 2014;341(1-2):79-84. 38. Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain. Jun 1997;13(2):163-170. 39. Buston K, Hart G. Heterosexism and homophobia in Scottish school sex education: exploring the nature of the problem. J Adolesc. Feb 2001;24(1):95-109. 40. Pitman GE. Body image, compulsory heterosexuality, and internalized homophobia. J Lesbian Stud. 1999;3(4):129-139. 41. Wagner G, Brondolo E, Rabkin J. Internalized homophobia in a sample of HIV+ gay men, and its relationship to psychological distress, coping, and illness progression. J Homosex. 1996;32(2):91-106. 42. Herek GM. Beyond 'homophobia': a social psychological perspective on attitudes toward lesbians and gay men. J Homosex. Fall 1984;10(1-2):1-21. 43. Chiu NC, Lin CY, Chi H, et al. Helicobacter pylori infection is not associated with failure to thrive: a case control study. Ther Clin Risk Manag. 2017;13:273-278. 44. Wu YL, Hwang DY, Hsiao HP, et al. Mutations in pseudohypoparathyroidism 1a and pseudopseudohypoparathyroidism in ethnic Chinese. PLoS One. 2014;9(3):e90640. 45. Huang CY, Ting WH, Lo FS, et al. The IL18 gene and Hashimoto thyroiditis in children. Hum Immunol. Jan 2013;74(1):120-124. 46. Ferraro FR, Dukart A. Cognitive inhibition in individuals prone to homophobia. J Clin Psychol. Feb 1998;54(2):155-162. 47. Lock J, Kleis B. Origins of homophobia in males. Psychosexual vulnerabilities and defense development. Am J Psychother. Fall 1998;52(4):425-436. 48. Sheard A. Homophobia in medicine. BMJ. Nov 28 1998;317(7171):1532E. 49. Kayal PM. Healing homophobia: Volunteerism and 'sacredness' in AIDS. J Relig Health. Jun 1992;31(2):113-128. 50. Kalman TP, Kalman CM, Connelly M, Perry SW. Homophobia reassessed. Hosp Community Psychiatry. Sep 1987;38(9):996. 51. Wong CM, Wu SY, Ting WH, Ho KH, Tong LH, Cheung NT. An Electronic Nursing Patient Care Plan Helps in Clinical Decision Support. Stud Health Technol Inform. 2015;216:945. 52. Chuang YC, Lu HF, Peng FS, et al. Modified novel technique for improving the success rate of applying seprafilm by using laparoscopy. J Minim Invasive Gynecol. Sep-Oct 2014;21(5):787-790. 53. Ting WH, Huang CY, Lo FS, et al. Improved diabetic control during oral sulfonylurea treatment in two children with permanent neonatal diabetes mellitus. J Pediatr Endocrinol Metab. Jul 2009;22(7):661-667. 54. Ting WH, Huang JS. Influence of mass transfer resistance on overall nitrate removal rate in upflow sludge bed reactors. Chemosphere. Sep 2006;65(1):148-158. 55. Yang VC, Kao CH, Ting WH, Chen KJ, Chiang BN. Structural changes in the mouse heart one year after brain exposure to 60Co gamma ray. Proc Natl Sci Counc Repub China B. Apr 1988;12(2):77-83. 56. Yuan SF, Guan JZ, Hao Y, et al. Effectiveness and Safety of the Combination of the Traditional Chinese Medicine Prescription Jade Screen and Desloratadine in the Treatment of Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med. 2017;2017:1390301. 57. Liu T, Li Y, Sadiq FA, et al. Predominant yeasts in Chinese traditional sourdough and their influence on aroma formation in Chinese steamed bread. Food Chem. Mar 1 2018;242:404-411. 58. Guo Q, Li Y, Yu S. In-Law and Mate Preferences in Chinese Society and the Role of Traditional Cultural Values. Evol Psychol. Jul-Sep 2017;15(3):1474704917730518. 59. Yu QP, Feng DY, He XJ, et al. Effects of a traditional Chinese medicine formula and its extraction on muscle fiber characteristICSI in finishing pigs, porcine cell proliferation and isoforms of myosin heavy chain gene expression in myocytes. Asian-Australas J Anim Sci. Nov 2017;30(11):1620-1632. 60. Yu N, Xiong Y, Wang C. Bu-Zhong-Yi-Qi Decoction, the Water Extract of Chinese Traditional Herbal Medicine, Enhances Cisplatin Cytotoxicity in A549/DDP Cells through Induction of Apoptosis and Autophagy. Biomed Res Int. 2017;2017:3692797. 61. Notice to Readers: Ongoing Analysis of Suicide Rates Data by Occupational Group from Results Reported in MMWR. MMWR Morb Mortal Wkly Rep. Jun 29 2018;67(25):729. 62. Leads from the MMWR. Plasmid-mediated tetracycline-resistant Neisseria gonorrhoeae--Georgia, Massachusetts, Oregon. JAMA. Jul 4 1986;256(1):25. 63. Leads from the MMWR. Rubella vaccination during pregnancy--United States, 1971-1985. JAMA. Jun 6 1986;255(21):2867, 2873, 2876. 64. Leads from the MMWR. Behavioral risk-factor surveillance--selected states, 1984. JAMA. May 23-30 1986;255(20):2735. 65. Leads from the MMWR. Cytotoxicity of volcanic ash: assessing the risk for pneumoconiosis. JAMA. May 23-30 1986;255(20):2727, 2731. 66. Leads from the MMWR. Premature mortality due to sudden infant death syndrome. JAMA. Apr 18 1986;255(15):1992-1993. 67. Leads from the MMWR. Update: prevention of Haemophilus influenzae type b disease. JAMA. Apr 18 1986;255(15):1990-1992. 68. Chen)。 黃M-CH林S-KL陳C-K. 從安非他命濫用到愷他命濫用(A Roller Coaster from Methamphetamine to Ketamine)。. 臺灣精神醫學 ; 28卷4期 (2014 / 12 / 01) , P217 - 231. 2014. 69. Lin)。 林J-TL陳P-CC陳J-CC林C-K. 愷他命相關潰瘍性膀胱炎:病例報告(Ketamine-Associated Ulcerative Cystitis: A Case Report)。. 台灣家庭醫學雜誌 ; 23卷2期 (2013 / 06 / 01) , P100 – 105. 2013. 70. 邱獻輝。 曾. 青少年愷他命使用者的心理探究(The Psychological Inquiry of Ketamine Abuse in Adolescents)。. 藥物濫用防治. 1卷1期 (2016 / 06 / 01) P79 - 105. 71. Hsu)。 張S-CC衛H-TW宋W-CS趙P-YJ許C-H. 愷他命使用者之中醫體質分析(Analysis of Traditional Chinese medical constitution among ketamine abusers.). 中西整合醫學雜誌 20卷1期 (2018 / 06 / 01) P9 - 19. 72. 齊沛瑜、王炯珵、陳心怡、唐宜楨、童伊迪。. K他命膀胱炎患者中止物質濫用歷程之探究。. 台灣衛誌 2018, Vol.37, No.2. 2018. 73. LIU)。 許L-YH劉M-F. 威權遺緒下的道德恐慌:民主轉型與臺灣的K他命政策(Moral Panic and the Legacy of Authoritarianism: Democratization and the Policies on Ketamine in Taiwan)。. 文化研究 2017;25期 (2017 / 12 / 01) P215 - 252. 74. Jheng) ; 林世智(Shih-Jhih Lin)。 楊S-LY許F-SH鄭K-PC顧Y-CK陳R-MC鄭Y-H. 三、四級毒品裁罰講習成效評估研究-以新北市為例(An evaluative study on the effectiveness of fine penalty and workshop for the third and fourth schedule drug users)。. 藥物濫用防治 2017;2卷2期 (2017 / 06 / 01) P1 - 45. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21681 | - |
dc.description.abstract | 背景與目的:愷他命使用會造成多重的健康危害。本研究探討愷他命使用者的使用型態與泌尿道症狀、憂鬱、焦慮等心身症狀之關聯性。
研究方法:於台北市毒品防治中心舉辦中三、四級毒品危害講習的愷他命使用者中,使用自填問卷方式評估使用者之基本資料、愷他命使用型態、透過貝式憂鬱量表(BDI)、簡式健康量表(BSRS)、下泌尿道症狀量表(IPSS)、以及間質性膀胱炎量表(ICSI) 評估受試者的心身科及泌尿科症狀。 研究結果:於2016年11月1日至2017年07月15日,共227位完成有效問卷,其中男性為170人(74.9%),年齡為28.74 6.40,職業分布中,以服務業(38.3%)為最多。首次使用愷他命年齡小於18歲103人(45.4%),18到29歲100人(44.0%),30歲以上24人(10.6%)。愷他命使用期間平均為55.04 49.97月。受試者的下泌尿症狀評分表(IPSS)平均得分為5.283.12分,中度異常(8-15分)共44人(18.1%),重度異常 (>15分)共16人(7.1%)。間質性膀胱炎症狀指標(ICSI)平均得分為2.92 3.11分,其中中度異常 (9-12分)共7人(3.1%),重度異常(>12分)共7人(3.1%)。貝式憂鬱量表(BDI)平均得分為13.565 9.64,其中中度異常(20-28分)共50人(22.0%),重度異常(29-63分)共15人(6.6%)。簡式健康量表(BSRS)平均得分4.79 4.51,中度異常(10-14分)共22人(9.7%),重度異常 (15-20分)共14人(6.2%)。 校正了年齡、性別、初次使用年齡、每日用量之後,愷他命使用時間與下泌尿道症狀指數(correlation factor:0.223, p<0.001)、間質性膀胱炎指數(correlation factor:0.155, p<0.05)、貝式憂鬱量表(correlation factor:0.066, p>0.05)、以及簡式憂鬱量表(correlation factor:0.168, p<0.05)皆呈現正相關。以BDI ≥ 20視為憂鬱困擾,並且在控制年齡與性別後,探討造成憂鬱困擾的風險因子以及其勝算比並且進行邏輯迴歸分析。其中,在下泌尿道症狀分數(IPSS)得分的組別中:正常/輕度(0-8),中度(8-15) 以及重度(>15)之勝算比(95%CI)分別為:1, 3.56(1.43-8.86) (p<0.01),9.48(1.96-46.00) (p<0.01)。 討論與建議:愷他命使用者之泌尿道及心身症狀之比例高,且泌尿道症狀及心身症狀呈現相關,較高的泌尿道症狀也預測了較嚴重的憂鬱症狀,這皆顯示了泌尿道與心身科症狀可能彼此影響,造成個案生理、心理層面的受損。因此,更多的臨床與政策面處遇應即時介入,以提升個案之生活品質,邁向復原之路。 | zh_TW |
dc.description.abstract | Background:
Ketamine use may result in multiple harms over bio-psycho-social aspects. This study aims to investigate the correlations between ketamine use profiles, lower urinary tract symptoms, and psychosomatic symptoms among ketamine users. Method: According to the Law for the Control of Narcotics in Taiwan, ketamine is a class III drug and considered an illegal substance of abuse. Participants of this study will be recruited from the forced education lectures after being arrested by police hours due to illegal ketamine use held by the Taipei City government. Self-administered questionnaires regarding demographic data, ketamine abuse profiles, Beck Depression Inventory, Brief Symptoms of Rating Scales (BSRS), International Prostate Symptoms Scale (IPSS), and Interstitial Cystitis Symptoms Index (ICSI) were delivered. The participants will complete informed consents under approval of the Institute of Review Board of the Taipei City Hospital. Results: A total of 227 participants had completed the investigation within the period from November 1st, 2016 to July 15th , 2017. Among the participants, 170人(74.9%) were male, with the mean age of 28.74 6.40, and main occupation to be in the service industry (38.3%). The history of ketamine use was 55.04 47.97 months while 103 (45.4%) started using ketamine before 18 years old. The IPSS score was 5.28 6.12 while 44(18.1%) and 16 (7.1%) people revealed moderate and severe impairment over lower urinary tract symptoms. The ICSI score was 2.92 3.11 while 7(3.1%) and 7(3.1%) people revealed moderate and severe impairment over interstitial cystitis symptoms. The BDI score was 13.56 9.64 while 50 (22.0%) and 15 (6.6%) revealed moderate to severe impairment over depressive symptoms. The BSRS score was 4.79 4.51 wile 22(9.7%) and 14(6.2%) revealed moderate to severe impairments over depressive symptoms. After adjusting the age, sex, first age of ketamine use and daily amounts, there is a positive correlation between ketamine use durations and IPSS scores (correlation factor:0.223, p<0.001), ICSI scores (correlation factor:0.155, p<0.05), BDI scores (correlation factor:0.168, p>0.05) and BSRS scores (correlation factor:0.168, p<0.05). Within the logistic regression models for prediction of depression (BDI ≥ 20), after adjusting age and sex, an increased odds ratio were noted within the groups with mild (IPSS: 0-8, Odds ratio:1), moderate (IPSS: 8-15, Odds ratio (95%CI): 3.56(1.43-8.86) p<0.01), and severe (IPSS>15, Odds ratio (95%CI): 9.48(1.96-46.00), p<0.01) urinary tract symptoms, prospectively. Discussion: There is a positive correlation between urinary tract symptoms and psychiatric symptoms among ketamine users. Both lower urinary tract symptoms and psychiatric may result in great health hazards and impairment over quality of life. Therefore, further researched regarding on prevention and treatments of urinary and psychiatric symptoms among ketamine users should be addressed. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T03:42:22Z (GMT). No. of bitstreams: 1 ntu-108-R04847038-1.pdf: 16451572 bytes, checksum: 96a4e874dfd9908ceef2878a50145ee3 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 口試委員審定書………………………………………………………………… I
致謝…………………………………………………………………………….... II 摘要……………………………………………………………………………… III Abstract………………………………………………………………………….. IV 目錄……………………………………………………………………………… VI 圖目錄…………………………………………………………………………… VIII 表目錄…………………………………………………………………………… IX 第一章、導論……………………………………………………………………. 1 第一節、實習單位簡介:昆明防治中心簡介……………. 1 第二節、研究背景與動機……………………………………………….. 4 第二章、文獻探討……………………………………………………………..… 5 第一節、藥物濫用之危害………………………………………………… 5 第二節、愷他命濫用介紹………………………………………………… 8 第三節、愷他命濫用與身心症狀…………………………………………. 10 第四節、愷他命毒品危害講習辦理情形…………………………… 12 第三章、研究方法………………………………………………………………........ 15 第一節、研究架構…………………………………………………………...... 15 第二節、研究設計…………………………………………………………. 15 第三節、研究變項的操作型定義………………………………………… 16 第四節、研究對象………………………………………………………… 18 第五節、研究工具………………………………………………………… 19 第六節、研究流程………………………………………………………… 23 第七節、資料處理以及統計分析方法………………………………… 24 第四章、研究結果………………………………………………………………........ 25 第一節、問卷回收結果…………………………………………………… 25 第二節、描述性分析……………………………………………………… 25 第三節、雙變項分析……………………………………………………… 41 第四節、多變項分析……………………………………………………… 50 第五章、討論………………………………………………….........………………… 51 第一節、愷他命濫用的風險………………………………………………. 51 第二節、愷他命濫用者的身心症狀……………………………………… 56 第三節、愷他命使用者的處遇策略……………………………………… 57 第四節、研究限制………………………………………………………… 58 第六章、結論與建議……………………………………………………………. 60 第一節、結論………………………………………………………………. 60 第二節、愷他命防治的實務建議………………………………………… 60 第三節、愷他命防治的政策建議………………………………………… 61 第四節、愷他命防治的管理建議…………………………………………. 61 第五節、愷他命防治的研究建議…………………………………………. 62 參考文獻………………………………………………………………................ 63 附錄一、台北市立聯合醫院研究倫理委員會審查證明…………… 69 附錄二、受試者同意書…………………………………………………………. 70 附錄三、受試者問卷……………………………………………………………. 75 | |
dc.language.iso | zh-TW | |
dc.title | 愷他命使用者之泌尿道與心身症狀分析 | zh_TW |
dc.title | Psychosomatic and lower urinary tract symptoms among ketamine abusers | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 莊苹(Ping Chung) | |
dc.contributor.oralexamcommittee | 周元華 | |
dc.subject.keyword | 愷他命濫用,心身症狀,下泌尿道症狀, | zh_TW |
dc.subject.keyword | Ketamine abuse,psychosomatic symptoms,lower urinary tract symptoms, | en |
dc.relation.page | 87 | |
dc.identifier.doi | 10.6342/NTU201900941 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2019-06-20 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 公共衛生碩士學位學程 | zh_TW |
顯示於系所單位: | 公共衛生碩士學位學程 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 16.07 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。